Published in Emerg Infect Dis on October 04, 2001
Vector competence of California mosquitoes for West Nile virus. Emerg Infect Dis (2002) 4.17
Zika Virus. Clin Microbiol Rev (2016) 3.34
Persistence of virus-reactive serum immunoglobulin m antibody in confirmed west nile virus encephalitis cases. Emerg Infect Dis (2003) 3.17
Pathogenesis of West Nile Virus infection: a balance between virulence, innate and adaptive immunity, and viral evasion. J Virol (2006) 3.15
CD8+ T cells mediate recovery and immunopathology in West Nile virus encephalitis. J Virol (2003) 2.69
Environmental and social determinants of human risk during a West Nile virus outbreak in the greater Chicago area, 2002. Int J Health Geogr (2004) 2.65
A nonsense mutation in the gene encoding 2'-5'-oligoadenylate synthetase/L1 isoform is associated with West Nile virus susceptibility in laboratory mice. Proc Natl Acad Sci U S A (2002) 2.65
Establishment and maintenance of the innate antiviral response to West Nile Virus involves both RIG-I and MDA5 signaling through IPS-1. J Virol (2007) 2.59
The host response to West Nile Virus infection limits viral spread through the activation of the interferon regulatory factor 3 pathway. J Virol (2004) 2.37
West Nile virus evades activation of interferon regulatory factor 3 through RIG-I-dependent and -independent pathways without antagonizing host defense signaling. J Virol (2006) 2.32
Unexpected inheritance: multiple integrations of ancient bornavirus and ebolavirus/marburgvirus sequences in vertebrate genomes. PLoS Pathog (2010) 2.32
Birds, migration and emerging zoonoses: west nile virus, lyme disease, influenza A and enteropathogens. Clin Med Res (2003) 2.00
West Nile virus isolation from equines in Argentina, 2006. Emerg Infect Dis (2006) 1.94
An epidemiological model for West Nile virus: invasion analysis and control applications. Proc Biol Sci (2004) 1.83
Protective and therapeutic capacity of human single-chain Fv-Fc fusion proteins against West Nile virus. J Virol (2005) 1.72
West Nile virus epidemic in horses, Tuscany region, Italy. Emerg Infect Dis (2002) 1.60
Local impact of temperature and precipitation on West Nile virus infection in Culex species mosquitoes in northeast Illinois, USA. Parasit Vectors (2010) 1.58
West Nile virus and its emergence in the United States of America. Vet Res (2010) 1.56
Phylogenetic relationships of southern African West Nile virus isolates. Emerg Infect Dis (2002) 1.55
Genetic determinants of virulence in pathogenic lineage 2 West Nile virus strains. Emerg Infect Dis (2008) 1.48
Ecological factors associated with West Nile virus transmission, northeastern United States. Emerg Infect Dis (2008) 1.47
West Nile virus surveillance and diagnostics: A Canadian perspective. Can J Infect Dis (2003) 1.44
Structure and function of the 3' terminal six nucleotides of the west nile virus genome in viral replication. J Virol (2004) 1.33
Preparation and immunogenic properties of a recombinant West Nile subunit vaccine. Vaccine (2006) 1.21
The global ecology and epidemiology of West Nile virus. Biomed Res Int (2015) 1.21
Relationships between host viremia and vector susceptibility for arboviruses. J Med Entomol (2006) 1.16
Avian host community structure and prevalence of West Nile virus in Chicago, Illinois. Oecologia (2008) 1.08
Ecology of West Nile virus in North America. Viruses (2013) 1.03
Comparison of mosquito trapping method efficacy for West Nile virus surveillance in New Mexico. J Am Mosq Control Assoc (2006) 1.00
Flavivirus RNA cap methyltransferase: structure, function, and inhibition. Front Biol (Beijing) (2010) 0.97
Immunogenicity and protective efficacy of a recombinant subunit West Nile virus vaccine in rhesus monkeys. Clin Vaccine Immunol (2009) 0.97
West Nile Virus infection in humans and horses, Cuba. Emerg Infect Dis (2006) 0.94
The capsid-binding nucleolar helicase DDX56 is important for infectivity of West Nile virus. J Virol (2011) 0.90
Complex adenovirus-mediated expression of West Nile virus C, PreM, E, and NS1 proteins induces both humoral and cellular immune responses. Clin Vaccine Immunol (2007) 0.88
May early intervention with high dose intravenous immunoglobulin pose a potentially successful treatment for severe cases of tick-borne encephalitis? BMC Infect Dis (2013) 0.87
Use of competition ELISA for monitoring of West Nile virus infections in horses in Germany. Int J Environ Res Public Health (2013) 0.86
Conservation and variability of West Nile virus proteins. PLoS One (2009) 0.85
Identification of multiple RIG-I-specific pathogen associated molecular patterns within the West Nile virus genome and antigenome. Virology (2012) 0.84
Print media coverage of risk-risk tradeoffs associated with West Nile encephalitis and pesticide spraying. J Urban Health (2002) 0.84
West Nile virus antibodies in permanent resident and overwintering migrant birds in south-central Kansas. Vector Borne Zoonotic Dis (2008) 0.84
A metapopulation model to simulate West Nile virus circulation in Western Africa, Southern Europe and the Mediterranean basin. Vet Res (2010) 0.83
Emerging infectious threats to the blood supply: seroepidemiological studies in iran - a review. Transfus Med Hemother (2013) 0.83
Differential Roles of Chemokines CCL2 and CCL7 in Monocytosis and Leukocyte Migration during West Nile Virus Infection. J Immunol (2015) 0.83
An integrated lab-on-chip for rapid identification and simultaneous differentiation of tropical pathogens. PLoS Negl Trop Dis (2014) 0.83
West Nile virus T-cell ligand sequences shared with other flaviviruses: a multitude of variant sequences as potential altered peptide ligands. J Virol (2012) 0.82
Generation of West Nile virus infectious clones containing amino acid insertions between capsid and capsid anchor. Viruses (2014) 0.81
Zika Virus as an Emerging Global Pathogen: Neurological Complications of Zika Virus. JAMA Neurol (2016) 0.80
High Prevalence of West Nile Virus in Domestic Birds and Detection in 2 New Mosquito Species in Madagascar. PLoS One (2016) 0.79
Integrins modulate the infection efficiency of West Nile virus into cells. J Gen Virol (2013) 0.79
In Vitro and in Vivo Evaluation of Mutations in the NS Region of Lineage 2 West Nile Virus Associated with Neuroinvasiveness in a Mammalian Model. Viruses (2016) 0.76
Detection of the mosquito-borne flaviviruses, West Nile, Dengue, Saint Louis Encephalitis, Ilheus, Bussuquara, and Yellow Fever in free-ranging black howlers (Alouatta caraya) of Northeastern Argentina. PLoS Negl Trop Dis (2017) 0.75
Review of West Nile virus circulation and outbreak risk in Madagascar: Entomological and ornithological perspectives. Parasite (2016) 0.75
The first investigation of west nile virus in horses using real time rt-PCR in middle black sea region in Turkey. J Arthropod Borne Dis (2012) 0.75
Chemokine Receptor Ccr7 Restricts Fatal West Nile Virus Encephalitis. J Virol (2017) 0.75
Increased pathogenicity of West Nile virus (WNV) by glycosylation of envelope protein and seroprevalence of WNV in wild birds in Far Eastern Russia. Int J Environ Res Public Health (2013) 0.75
West Nile virus. Primer for family physicians. Can Fam Physician (2005) 0.75
West nile virus infection in the United States: overview as a public health issue. Ochsner J (2003) 0.75
An outbreak of West Nile Virus infection in the region of Monastir, Tunisia, 2003. Pathog Glob Health (2014) 0.75
West Nile virus and hemoparasites in captive snowy owls (Bubo scandiacus)--management strategies to optimize survival. Can Vet J (2008) 0.75
Agriculture emergencies: a primer for first responders. Biosecur Bioterror (2009) 0.75
West Nile virus and the 2012 outbreak: The Baylor University Medical Center experience. Proc (Bayl Univ Med Cent) (2015) 0.75
Comparison of β-Propiolactone and Formalin Inactivation on Antigenicity and Immune Response of West Nile Virus. Adv Virol (2015) 0.75
Seroprevalence of St. Louis encephalitis virus and West Nile virus (Flavivirus, Flaviviridae) in horses, Uruguay. Biomed Res Int (2013) 0.75
In vitro and in vivo characterization of a West Nile virus MAD78 infectious clone. Arch Virol (2014) 0.75
Whole genome phylogenetic investigation of a West Nile virus strain isolated from a tick sampled from livestock in north eastern Kenya. Parasit Vectors (2014) 0.75
Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States. Science (1999) 18.55
Rapid detection of west nile virus from human clinical specimens, field-collected mosquitoes, and avian samples by a TaqMan reverse transcriptase-PCR assay. J Clin Microbiol (2000) 13.34
The outbreak of West Nile virus infection in the New York City area in 1999. N Engl J Med (2001) 11.48
West Nile encephalitis epidemic in southeastern Romania. Lancet (1998) 7.73
West Nile fever--a reemerging mosquito-borne viral disease in Europe. Emerg Infect Dis (1999) 7.50
Pathology of fatal West Nile virus infections in native and exotic birds during the 1999 outbreak in New York City, New York. Vet Pathol (2000) 6.46
Crow deaths as a sentinel surveillance system for West Nile virus in the northeastern United States, 1999. Emerg Infect Dis (2001) 5.83
Climate change and mosquito-borne disease. Environ Health Perspect (2001) 5.31
Dengue/dengue hemorrhagic fever: the emergence of a global health problem. Emerg Infect Dis (1996) 5.03
Entomologic and avian investigations of an epidemic of West Nile fever in Romania in 1996, with serologic and molecular characterization of a virus isolate from mosquitoes. Am J Trop Med Hyg (1999) 4.62
The West Nile Virus outbreak of 1999 in New York: the Flushing Hospital experience. Clin Infect Dis (2000) 3.86
Extensive nucleotide changes and deletions within the envelope glycoprotein gene of Euro-African West Nile viruses. J Gen Virol (1997) 3.78
Indigenous wild birds of the Nile Delta as potential West Nile virus circulating reservoirs. Am J Trop Med Hyg (1955) 3.48
Update: West Nile Virus activity--Eastern United States, 2000. MMWR Morb Mortal Wkly Rep (2000) 3.30
West Nile outbreak in horses in southern France, 2000: the return after 35 years. Emerg Infect Dis (2001) 3.16
Genetic analysis of West Nile New York 1999 encephalitis virus. Lancet (1999) 3.12
Clinical findings of West Nile virus infection in hospitalized patients, New York and New Jersey, 2000. Emerg Infect Dis (2001) 2.97
Detection of West Nile virus sequences in cerebrospinal fluid. Lancet (2000) 2.83
Partial genetic characterization of West Nile virus strains, New York State, 2000. Emerg Infect Dis (2001) 2.82
Outbreak of West Nile virus infection, Volgograd Region, Russia, 1999. Emerg Infect Dis (2001) 2.72
The global pandemic of dengue/dengue haemorrhagic fever: current status and prospects for the future. Ann Acad Med Singapore (1998) 2.68
Widespread West Nile virus activity, eastern United States, 2000. Emerg Infect Dis (2001) 2.52
West Nile virus in overwintering Culex mosquitoes, New York City, 2000. Emerg Infect Dis (2001) 2.48
First field evidence for natural vertical transmission of West Nile virus in Culex univittatus complex mosquitoes from Rift Valley province, Kenya. Am J Trop Med Hyg (2000) 2.44
Clinical characteristics of the West Nile fever outbreak, Israel, 2000. Emerg Infect Dis (2001) 2.34
West Nile virus surveillance in Connecticut in 2000: an intense epizootic without high risk for severe human disease. Emerg Infect Dis (2001) 2.26
An outbreak of Japanese encephalitis in the Torres Strait, Australia, 1995. Med J Aust (1996) 2.25
Dead crow densities and human cases of West Nile virus, New York State, 2000. Emerg Infect Dis (2001) 2.17
West Nile virus infection in mosquitoes, birds, horses, and humans, Staten Island, New York, 2000. Emerg Infect Dis (2001) 2.16
West Nile fever outbreak, Israel, 2000: epidemiologic aspects. Emerg Infect Dis (2001) 2.15
Mosquito surveillance for West Nile virus in Connecticut, 2000: isolation from Culex pipiens, Cx. restuans, Cx. salinarius, and Culiseta melanura. Emerg Infect Dis (2001) 2.15
A case of natural concurrent human infection with two dengue viruses. Am J Trop Med Hyg (1985) 2.04
Fatal encephalitis and myocarditis in young domestic geese (Anser anser domesticus) caused by West Nile virus. Emerg Infect Dis (2001) 2.03
Risk factors for West Nile virus infection and meningoencephalitis, Romania, 1996. J Infect Dis (1999) 2.03
The relationships between West Nile and Kunjin viruses. Emerg Infect Dis (2001) 2.03
Japanese encephalitis in north Queensland, Australia, 1998. Med J Aust (1999) 1.96
Detection of North American West Nile virus in animal tissue by a reverse transcription-nested polymerase chain reaction assay. Emerg Infect Dis (2001) 1.70
A high number of severe neurologic clinical forms during an epidemic of West Nile virus infection. Rom J Virol (1999) 1.69
Mosquito surveillance and polymerase chain reaction detection of West Nile virus, New York State. Emerg Infect Dis (2001) 1.60
Isolation of Japanese encephalitis virus from Culex annulirostris in Australia. Am J Trop Med Hyg (1997) 1.45
West Nile encephalitis in Israel, 1999: the New York connection. Emerg Infect Dis (2001) 1.39
Isolation and characterization of West Nile virus from the blood of viremic patients during the 2000 outbreak in Israel. Emerg Infect Dis (2001) 1.37
Dengue and dengue hemorrhagic fever in the Americas. P R Health Sci J (1987) 1.26
Arboviruses in the Australian region, 1990 to 1998. Commun Dis Intell (1998) 1.22
Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States. Science (1999) 18.55
Rapid detection of west nile virus from human clinical specimens, field-collected mosquitoes, and avian samples by a TaqMan reverse transcriptase-PCR assay. J Clin Microbiol (2000) 13.34
Nipah virus: a recently emergent deadly paramyxovirus. Science (2000) 9.39
Standardization of immunoglobulin M capture enzyme-linked immunosorbent assays for routine diagnosis of arboviral infections. J Clin Microbiol (2000) 8.80
Detection of anti-arboviral immunoglobulin G by using a monoclonal antibody-based capture enzyme-linked immunosorbent assay. J Clin Microbiol (2000) 4.61
Monoclonal antibodies that bind to domain III of dengue virus E glycoprotein are the most efficient blockers of virus adsorption to Vero cells. J Virol (2001) 4.27
Construction of infectious cDNA clones for dengue 2 virus: strain 16681 and its attenuated vaccine derivative, strain PDK-53. Virology (1997) 3.48
Identification of epitopes on the E glycoprotein of Saint Louis encephalitis virus using monoclonal antibodies. Virology (1983) 3.24
New mouse model for dengue virus vaccine testing. J Virol (1999) 3.18
Attenuation of Venezuelan equine encephalitis virus strain TC-83 is encoded by the 5'-noncoding region and the E2 envelope glycoprotein. J Virol (1993) 2.69
Widespread West Nile virus activity, eastern United States, 2000. Emerg Infect Dis (2001) 2.52
The Murray Valley encephalitis virus prM protein confers acid resistance to virus particles and alters the expression of epitopes within the R2 domain of E glycoprotein. Virology (1992) 2.48
Mayaro virus disease: an emerging mosquito-borne zoonosis in tropical South America. Clin Infect Dis (1999) 1.93
West Nile virus in the United States: guidelines for detection, prevention, and control. Viral Immunol (2000) 1.85
Antigenic analysis of the surface glycoproteins of a Venezuelan equine encephalomyelitis virus (TC-83) using monoclonal antibodies. Virology (1982) 1.80
The neutralization site on the E2 glycoprotein of Venezuelan equine encephalomyelitis (TC-83) virus is composed of multiple conformationally stable epitopes. Virology (1985) 1.62
Determination of the protective epitopes on the glycoproteins of Venezuelan equine encephalomyelitis virus by passive transfer of monoclonal antibodies. J Immunol (1982) 1.60
Elucidation of the topography and determination of the protective epitopes on the E glycoprotein of Saint Louis encephalitis virus by passive transfer with monoclonal antibodies. J Immunol (1984) 1.58
Selection and partial characterization of dengue 2 virus mutants that induce fusion at elevated pH. Virology (1993) 1.56
Venezuelan equine encephalitis and Oropouche virus infections among Peruvian army troops in the Amazon region of Peru. Am J Trop Med Hyg (1997) 1.45
The role of pathology in an investigation of an outbreak of West Nile encephalitis in New York, 1999. Emerg Infect Dis (2000) 1.43
The envelope glycoproteins of dengue 1 and dengue 2 viruses grown in mosquito cells differ in their utilization of potential glycosylation sites. Virology (1994) 1.33
Monoclonal antibodies against the flavivirus West Nile. J Gen Virol (1982) 1.33
Venezuelan equine encephalitis febrile cases among humans in the Peruvian Amazon River region. Am J Trop Med Hyg (1998) 1.30
Detection of St. Louis encephalitis virus antigen in mosquitoes by capture enzyme immunoassay. J Clin Microbiol (1987) 1.29
Isolation and characterization of hybrid cell lines producing monoclonal antibodies directed against the structural proteins of Sindbis virus. Virology (1980) 1.28
Variants of Venezuelan equine encephalitis virus that resist neutralization define a domain of the E2 glycoprotein. Virology (1990) 1.25
Development of an enzyme-linked immunosorbent assay for the identification of arthropod-borne togavirus antibodies. J Gen Virol (1982) 1.24
Improved clarity of meaning from the use of both formal species names and common (vernacular) virus names in virological literature. Arch Virol (2002) 1.22
Analysis of a yellow fever virus isolated from a fatal case of vaccine-associated human encephalitis. J Infect Dis (1994) 1.18
Role of complement and the Fc portion of immunoglobulin G in immunity to Venezuelan equine encephalomyelitis virus infection with glycoprotein-specific monoclonal antibodies. J Virol (1985) 1.18
Identification of Highlands J virus from a Florida horse. Am J Trop Med Hyg (1988) 1.16
Biochemical and biological characteristics of epitopes on the E1 glycoprotein of western equine encephalitis virus. Virology (1985) 1.12
Recombinant vaccinia virus/Venezuelan equine encephalitis (VEE) virus protects mice from peripheral VEE virus challenge. J Virol (1988) 1.10
A single amino acid change in the E2 glycoprotein of Venezuelan equine encephalitis virus affects replication and dissemination in Aedes aegypti mosquitoes. J Gen Virol (1991) 1.10
Properties of monoclonal antibodies directed against the glycoproteins of Sindbis virus. J Gen Virol (1982) 1.09
Stability of St. Louis encephalitis viral antigen detected by enzyme immunoassay in infected mosquitoes. J Clin Microbiol (1988) 1.08
Synthetic peptides of the E2 glycoprotein of Venezuelan equine encephalomyelitis virus. II. Antibody to the amino terminus protects animals by limiting viral replication. Virology (1991) 1.05
Monoclonal antibodies define antigenic variation in the ID variety of Venezuelan equine encephalitis virus. Am J Trop Med Hyg (1988) 1.04
Murray valley encephalitis virus envelope protein antigenic variants with altered hemagglutination properties and reduced neuroinvasiveness in mice. Virology (1995) 1.02
Emergence of epidemic O'nyong-nyong fever in southwestern Uganda, after an absence of 35 years. Emerg Infect Dis (1997) 1.02
Antigenic structure of the Murray Valley encephalitis virus E glycoprotein. J Gen Virol (1988) 1.01
Genetic variation of Venezuelan equine encephalitis virus strains of the ID variety in Colombia. Am J Trop Med Hyg (1988) 1.00
Molecular and biological characterization of a non-glycosylated isolate of St Louis encephalitis virus. J Gen Virol (1993) 1.00
Synthetic peptides of Venezuelan equine encephalomyelitis virus E2 glycoprotein. I. Immunogenic analysis and identification of a protective peptide. Virology (1990) 0.97
West Nile virus. JAMA (2001) 0.94
Recombinant vaccinia/Venezuelan equine encephalitis (VEE) virus expresses VEE structural proteins. J Gen Virol (1988) 0.93
Nucleotide sequences of the 26S mRNAs of the viruses defining the Venezuelan equine encephalitis antigenic complex. Am J Trop Med Hyg (1998) 0.92
Identification of an antigenic subtype of eastern equine encephalitis virus isolated from a human. J Clin Microbiol (1990) 0.91
T-helper cell and associated antibody response to synthetic peptides of the E glycoprotein of Murray Valley encephalitis virus. J Virol (1991) 0.88
Identification of monoclonal antibodies that distinguish between 17D-204 and other strains of yellow fever virus. J Gen Virol (1990) 0.86
Specificity of the murine T helper cell immune response to various alphaviruses. J Gen Virol (1989) 0.85
Detection of eastern equine encephalitis virus in infected mosquitoes using a monoclonal antibody-based antigen-capture enzyme-linked immunosorbent assay. Am J Trop Med Hyg (2001) 0.81
Defined epitope blocking with Murray Valley encephalitis virus and monoclonal antibodies: laboratory and field studies. J Med Virol (1990) 0.81
Characteristics of a persistent rubella infection in a human cell line. J Gen Virol (1981) 0.80
Effects of 17beta-estradiol on the replication of rubella virus in an estrogen-responsive, continuous cell line. J Virol (1979) 0.80
Differentiation of parapoxviruses by application of orf virus-specific monoclonal antibodies against cell surface proteins. Vet Immunol Immunopathol (1991) 0.78
Nocodazole delays viral entry into the brain following footpad inoculation with West Nile virus in mice. J Neurovirol (2009) 0.76
A synthetic peptide to the E glycoprotein of Murray Valley encephalitis virus defines multiple virus-reactive T- and B-cell epitopes. J Virol (1992) 0.75
Laboratory testing for West Nile virus: panel discussion. Ann N Y Acad Sci (2001) 0.75
Development of a functional monoclonal single-chain variable fragment antibody against Venezuelan equine encephalitis virus. Hybridoma (1999) 0.75
Murine T-helper cell immune response to recombinant vaccinia-Venezuelan equine encephalitis virus. Vaccine (1994) 0.75